Raymond V Dittamore - Net Worth and Insider Trading

Raymond V Dittamore Net Worth

The estimated net worth of Raymond V Dittamore is at least $3 Million dollars as of 2024-04-24. Raymond V Dittamore is the Director of Qualcomm Inc and owns about 19,539 shares of Qualcomm Inc (QCOM) stock worth over $3 Million. Raymond V Dittamore is the Director of GoPro Inc and owns about 2,241 shares of GoPro Inc (GPRO) stock worth over $4,011. Raymond V Dittamore is also the Director of Star Equity Holdings Inc and owns about 600 shares of Star Equity Holdings Inc (STRR) stock worth over $531. Besides these, Raymond V Dittamore also holds aTyr Pharma Inc (LIFE) . Details can be seen in Raymond V Dittamore's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Raymond V Dittamore has not made any transactions after 2016-09-30 and currently still holds the listed stock(s).

Transaction Summary of Raymond V Dittamore

To

Raymond V Dittamore Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Raymond V Dittamore owns 4 companies in total, including Obalon Therapeutics Inc (OBLN) , Qualcomm Inc (QCOM) , and Star Equity Holdings Inc (STRR) among others .

Click here to see the complete history of Raymond V Dittamore’s form 4 insider trades.

Insider Ownership Summary of Raymond V Dittamore

Ticker Comapny Transaction Date Type of Owner
OBLN Obalon Therapeutics Inc 2020-09-16 director
QCOM Qualcomm Inc 2016-09-30 director
STRR Star Equity Holdings Inc 2005-05-26 director
RSLS Reshape Lifesciences Inc 2016-10-05 director

Raymond V Dittamore Latest Holdings Summary

Raymond V Dittamore currently owns a total of 4 stocks. Among these stocks, Raymond V Dittamore owns 19,539 shares of Qualcomm Inc (QCOM) as of September 30, 2016, with a value of $3 Million and a weighting of 99.84%. Raymond V Dittamore owns 2,241 shares of GoPro Inc (GPRO) as of August 6, 2007, with a value of $4,011 and a weighting of 0.13%. Raymond V Dittamore also owns 600 shares of Star Equity Holdings Inc (STRR) as of June 10, 2004, with a value of $531 and a weighting of 0.02%. The other 1 stocks aTyr Pharma Inc (LIFE) have a combined weighting of 0.01% among all his current holdings.

Latest Holdings of Raymond V Dittamore

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
QCOM Qualcomm Inc 2016-09-30 19,539 161.35 3,152,618
GPRO GoPro Inc 2007-08-06 2,241 1.79 4,011
STRR Star Equity Holdings Inc 2004-06-10 600 0.89 531
LIFE aTyr Pharma Inc 2012-01-25 289 1.62 468

Holding Weightings of Raymond V Dittamore


Raymond V Dittamore Form 4 Trading Tracker

According to the SEC Form 4 filings, Raymond V Dittamore has made a total of 0 transactions in Qualcomm Inc (QCOM) over the past 5 years. The most-recent trade in Qualcomm Inc is the sale of 18,000 shares on September 30, 2016, which brought Raymond V Dittamore around $1 Million.

According to the SEC Form 4 filings, Raymond V Dittamore has made a total of 0 transactions in GoPro Inc (GPRO) over the past 5 years. The most-recent trade in GoPro Inc is the sale of 13,000 shares on August 6, 2007, which brought Raymond V Dittamore around $845,000.

According to the SEC Form 4 filings, Raymond V Dittamore has made a total of 0 transactions in Star Equity Holdings Inc (STRR) over the past 5 years. The most-recent trade in Star Equity Holdings Inc is the acquisition of 600 shares on June 10, 2004, which cost Raymond V Dittamore around $72,000.

More details on Raymond V Dittamore's insider transactions can be found in the Insider Trading History of Raymond V Dittamore table.

Insider Trading History of Raymond V Dittamore

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Raymond V Dittamore Trading Performance

GuruFocus tracks the stock performance after each of Raymond V Dittamore's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Raymond V Dittamore is 2.68%. GuruFocus also compares Raymond V Dittamore's trading performance to market benchmark return within the same time period. The performance of stocks bought by Raymond V Dittamore within 3 months outperforms 2 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Raymond V Dittamore's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Raymond V Dittamore

Average Return

-1.82%

Average return per transaction

Outperforming Transactions

67%

2 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -4.62 2.68 -0.75 -1.82 -8.7 -5.36
Relative Return to S&P 500(%) -6.72 -1.68 -8.48 -11.01 -17.86 -14.44

Raymond V Dittamore Ownership Network

Ownership Network List of Raymond V Dittamore

No Data

Ownership Network Relation of Raymond V Dittamore


Raymond V Dittamore Owned Company Details

What does Obalon Therapeutics Inc do?

Who are the key executives at Obalon Therapeutics Inc?

Raymond V Dittamore is the director of Obalon Therapeutics Inc. Other key executives at Obalon Therapeutics Inc include director & President & CEO & Exec Chairman Andrew P Rasdal , Chief Financial Officer Nooshin Hussainy , and Chief Technology Officer Mark Brister .

Obalon Therapeutics Inc (OBLN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Obalon Therapeutics Inc (OBLN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Obalon Therapeutics Inc (OBLN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Obalon Therapeutics Inc (OBLN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Obalon Therapeutics Inc Insider Transactions

No Available Data

Raymond V Dittamore Mailing Address

Above is the net worth, insider trading, and ownership report for Raymond V Dittamore. You might contact Raymond V Dittamore via mailing address: P O Box 2050, Glenwood Springs Co 81602.

Discussions on Raymond V Dittamore

No discussions yet.